University of Massachusetts Memorial Health Care
Welcome,         Profile    Billing    Logout  
 10 Trials 
10 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Evens, Andrew M
NCT05551936: A Study of Tazemetostat With Rituximab and Abbreviated Bendamustine in the Frontline Treatment of High Tumor Burden Follicular Lymphoma

Recruiting
1/2
42
US
Bendamustine, Bendeka, Treanda, Rituximab, Rituxan, Tazemetostat, Tazverik
Vaishalee Kenkre, Epizyme, Inc., University of Wisconsin, Madison
Follicular Lymphoma
05/26
05/27
NCT04431635: Dose De-escalation Study of the PI3k Alpha/Delta Inhibitor, Copanlisib Given in Combination With the Immunotherapeutic Agents, Nivolumab and Rituximab in Patients With Relapsed/Refractory Indolent Lymphoma

Terminated
1
6
US
Copanlisib, Nivolumab, Rituximab
University of Michigan Rogel Cancer Center, Bayer, Bristol-Myers Squibb, University of Michigan, Big Ten Cancer Research Consortium
Indolent Lymphoma
11/23
11/23
NCT03601442: CTL019 Out of Specification MAP for ALL or DLBCL Patients

Available
N/A
Canada, US, RoW
CTL019, tisagenlecleucel, Kymriah
Novartis Pharmaceuticals
Acute Lymphoblastic Leukemia (ALL), Diffuse Large B-cell Lymphoma (DLBCL)
 
 
NCT06002828: Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors

Recruiting
N/A
2000
US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration
ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI)
Hodgkin Lymphoma, Non-Hodgkin Lymphoma
02/30
02/30
realMIND, NCT04981795: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL

Recruiting
N/A
100
US
Tafasitamab
Incyte Corporation, Iqvia Pty Ltd
Diffuse Large B-cell Lymphoma
10/25
08/26
Cerny, Jan
AIM4CML, NCT04666259: Asciminib in Monotherapy for Chronic Myeloid Leukemia in Chronic Phase (CML-CP) With and Without T315I Mutation

Completed
3
56
US
ABL001
Novartis Pharmaceuticals
Chronic Myelogenous Leukemia - Chronic Phase
06/23
06/24
NCT01351545: A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Recruiting
N/A
99999
US
A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs)
Center for International Blood and Marrow Transplant Research, National Marrow Donor Program
Hematologic Malignancies, Inherited Disorders of Metabolism, Inherited Abnormalities of Platelets, Histiocytic Disorders, Acute Myelogenous Leukemia (AML or ANLL), Acute Lymphoblastic Leukemia (ALL), Other Acute Leukemia, Chronic Myelogenous Leukemia (CML), Myelodysplastic (MDS) / Myeloproliferative (MPN) Diseases, Other Leukemia, Hodgkin Lymphoma, Non-hodgkin Lymphoma, Multiple Myeloma/ Plasma Cell Disorder (PCD), Inherited Abnormalities of Erythrocyte Differentiation or Function, Disorders of the Immune System, Autoimmune Diseases, Severe Aplastic Anemia
10/41
10/41
NCT01174615: Collection of Blood and/or Bone Marrow for Investigation and Characterization of Normal and Abnormal Cell Growth

Withdrawn
N/A
1000
US
University of Massachusetts, Worcester
Leukemia
12/99
12/00
Longtine, Jaclyn
STOP360AG, NCT05548283: Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study

Recruiting
4
730
Canada, US
Beta-lactam antibiotic, β-lactam, Aminoglycoside, AG
Chris Goss, University of Washington, Medical University of South Carolina, Cystic Fibrosis Foundation
Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation
11/26
11/26
NCT06504589: A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

Recruiting
N/A
400
US
Nicole Hamblett, Washington University School of Medicine, Florida State University, University of North Carolina, Chapel Hill, University of Toronto, Cystic Fibrosis Foundation
Cystic Fibrosis
08/29
08/29
Longtine, Karen
No trials found
Kremer, Ted
No trials found

Download Options